GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.26) by 38.46 percent. This is a 52.94 percent increase over losses of $(0.34) per share from the same period last year.
Oracle Likely To Report Lower Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Oracle Corporation (NYSE:ORCL) will release earnings results for its fourth quarter, after the closing bell on Tuesday. Analysts…
